Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marcelo V. Negrao"'
Autor:
Xiuning Le, Lingzhi Hong, Chuck Hensel, Rongrong Chen, Haley Kemp, Niamh Coleman, Christine A. Ciunci, Stephen V. Liu, Marcelo V. Negrao, Jennifer Yen, Xuefeng Xia, Juergen Scheuenpflug, Christopher Stroh, Dilafruz Juraeva, Anne Tsao, David Hong, Victoria Raymond, Paul Paik, Jianjun Zhang, John V. Heymach
Publikováno v:
JCO Precision Oncology
PURPOSE MET exon 14 skipping alterations ( METex14) comprise a diverse set of actionable oncogene drivers in non–small-cell lung cancer (NSCLC). Recent studies have established the efficacy of tyrosine kinase inhibitors for this patient population.
Autor:
Lei Feng, Jacqulyne P. Robichaux, Yasir Elamin, Jianjun Zhang, Brett W. Carter, Don L. Gibbons, George R. Blumenschein, John V. Heymach, Frank E. Mott, Mehmet Altan, Marcelo V. Negrao, Vincent K. Lam, Frank V. Fossella, Anisha B. Patel, Anne S. Tsao, Xiuning Le
Publikováno v:
J Clin Oncol
PURPOSE Targeted therapies against non–small-cell lung cancer (NSCLC) harboring HER2 mutations remain an unmet need. In this study, we assessed the efficacy and safety of poziotinib in patients with HER2 exon 20 mutant advanced NSCLC in a single-ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce847f3cddbf0739c9448e42355323c1
https://europepmc.org/articles/PMC8887948/
https://europepmc.org/articles/PMC8887948/